The essential role of mTORC1 in lipogenesis is underlined by the observation that SREBP1 activation is prevented by the mTOR inhibitor rapamycin and that mTOR-deficient mice are protected from HFD-induced liver steatosis39–41. Here, MTOR is linked to digestive system neoplasm.